WHO ICTRP trial
A retrospective study on the real world of Xuebijing Injection
ChiCTR2100045106 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100045106 |
|---|---|
| Public title | A retrospective study on the real world of Xuebijing Injection |
| Scientific title | A retrospective study on the real world of Xuebijing Injection |
| Primary sponsor | Department of Pharmacy, Guangdong Provincial People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Conditions | Sepsis |
| Interventions | Exposure Group(Xuebijing Group):Treatment with Xuebijing;Non-exposed Group(non-Xuebijing group):Not treated with Xuebijing |
| Registration date | Apr 6, 2021 |
| Target size | Exposure Group(Xuebijing Group):5000;Non-exposed Group(non-Xuebijing… |
| Secondary IDs | ChiMCTR2100004700 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: